In the present work, we have studied the effect of IL-21 sequestration in different clinical stages by administering adeno-associated vectors (AAV) encoding a soluble IL-21R (sIL21R) capable of selectively blocking the function of IL-21 in an EAE mouse model of MS. The gene discussed is IL21R; the disease is myeloid sarcoma.